Skip to main content
logo
Everest Medicines Limited (HKG:1952)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.76
-2.46 (-7.88%)
Sep 10, 2026, 1:15 PM HKT

Everest Medicines Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,97613,06515,5926,6985,37510,326
Market Cap Growth
-49.96%-16.21%132.78%24.63%-47.95%-47.98%
Enterprise Value
10,92312,13213,6304,3063,7126,099
Last Close Price
31.2236.9848.4020.9017.3834.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
18.7295.03----
PS Ratio
3.956.8820.7348.28371.66155778.93
PB Ratio
1.822.213.601.220.841.43
P/TBV Ratio
8.153.658.062.491.452.46

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.936.3918.1231.04256.6592015.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.380.180.140.110.100.09
Net Debt / Equity Ratio
-0.01-0.34-0.25-0.36-0.20-0.36
Net Debt / EBITDA Ratio
-1.878.551.532.280.802.04
Net Debt / FCF Ratio
0.1611.531.382.040.742.53
Asset Turnover
0.360.290.130.020.000
Inventory Turnover
9.0722.6711.012.250.77-
Quick Ratio
3.414.762.517.553.849.84
Current Ratio
3.774.892.547.633.929.95
Return on Equity (ROE)
-1.18%-6.35%-23.04%-15.90%-4.28%-15.84%
Return on Assets (ROA)
-1.06%-3.65%-9.09%-8.59%-13.24%-9.29%
Return on Capital Employed (ROCE)
-1.50%-5.60%-18.70%-15.60%-24.50%-16.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.57%-2.54%-7.11%-13.89%-5.20%-11.99%
FCF Yield
-2.96%-1.33%-5.08%-14.58%-31.80%-9.98%
Buyback Yield / Dilution
-0.03%-4.84%-2.51%-5.18%-1.49%-243.61%